Health ❯ Healthcare

Regulatory Agencies

FDA MHRA Anvisa European Medicines Agency Drug Approval Process ANSM Food and Drug Administration ANMAT AEMPS Drug Approval

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

The move follows FDA analyses of 91 trials plus a 2.24 million‑patient claims study that found no increased risk.

UK Approves First Twice-Yearly Asthma Biologic as GSK Targets 2026 Launch

FDA Approves First Wegovy Pill for Chronic Weight Management

MediNatura Recalls All ReBoost and ClearLife Nasal Sprays Over Contamination Risk

Brazil Approves Butantan’s Single‑Dose Dengue Vaccine, With SUS Rollout Set for January

Anvisa Bans 30 Landerlan Anabolic Products Over Lack of Registration

MHRA Issues Festive-Season Alert on Alcohol–Medicine Risks and Paracetamol Overdose

Recalls Expand for Abbott FreeStyle Libre 3 Sensors Over False Low Readings

Abbott Recalls FreeStyle Libre 3 Sensors in 17 Countries After Reports of False Low Readings

FDA Names Tracy Beth Høeg Acting CDER Director as OTC Drugs Chief Is Reassigned

Anvisa Prohibits Prosatril, Erenobis and Óliver Turbo in DOU Determination

FDA Installs Tracy Beth Hoeg as Acting CDER Director as Pazdur Files Retirement

Walgreens Recalls Saline Nasal Spray After FDA Flags Bacterial Contamination

Australia Tightens Access to High‑Dose Vitamin B6 With New Pharmacist and Prescription Rules

Denmark Awards Compensation to Four Patients for Eye Damage Linked to Ozempic and Wegovy

FDA Drops Broad Black-Box Warnings on Menopause Hormone Therapy

Russia Probes Reports of CGM Sensor Shortfalls as Regions Deny Gaps

FDA Drops Black-Box Warning From Menopausal Hormone Therapies After Evidence Review

FDA Issues Warning Letters to 18 Websites Selling Unapproved Botox-Like Injectables

FDA Warns RF Microneedling Poses Serious Risk of Disfigurement